Position in UTHR
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$833,876
+$194,644 QoQ
Shares Held
1,539
+42.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#490
of 877 holders
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ethic Inc. holds $15,329,079 across 10 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
365,253 | $5,855,005 | |
| 2 | ZTS |
Zoetis Inc.
|
40,796 | $2,931,600 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
132,074 | $1,913,752 | |
| 4 | HLN |
Haleon plc
|
109,770 | $1,024,154 | |
| 5 | VTRS |
Viatris Inc
|
53,626 | $851,580 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
1,539 | $833,876 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
33,453 | $823,278 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,171 | $683,393 |
All Filings in UTHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $833,876 | 1,539 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $639,232 | 1,078 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $465,811 | 956 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $365,970 | 873 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $258,902 | 901 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $245,691 | 797 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $959,019 | 2,718 | Shares | Sole | 2025-02-14 | |
| 2023-12-31 | $303,228 | 1,379 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $233,775 | 1,035 | Shares | Sole | 2023-11-14 | |
| 2022-03-31 | $443,501 | 2,472 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||